Using Lactose and Ultrasound to deliver chemotherapeutics

A Master of Science thesis in Biomedical Engineering by Rand Hasan Abusamra entitled, “Using Lactose and Ultrasound to deliver chemotherapeutics”, submitted in May 2019. Thesis advisor is Dr. Ghaleb Husseini. Soft and hard copy available.

Saved in:
Bibliographic Details
Main Author: Abusamra, Rand Hasan (author)
Format: doctoralThesis
Published: 2019
Subjects:
Online Access:http://hdl.handle.net/11073/16440
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513435773960192
author Abusamra, Rand Hasan
author_facet Abusamra, Rand Hasan
author_role author
dc.contributor.none.fl_str_mv Husseini, Ghaleb
dc.creator.none.fl_str_mv Abusamra, Rand Hasan
dc.date.none.fl_str_mv 2019-05-21T09:54:28Z
2019-05-21T09:54:28Z
2019-05
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.identifier.none.fl_str_mv 35.232-2019.07
http://hdl.handle.net/11073/16440
dc.language.none.fl_str_mv en_US
dc.subject.none.fl_str_mv Drug Delivery
Chemotherapy
Liposomes
Lactobionic Acid Ultrasound
Kinetic modeling
Chemotherapy
Drug delivery systems
Ultrasonics in medicine
Lactose
Nanobiotechnology
dc.title.none.fl_str_mv Using Lactose and Ultrasound to deliver chemotherapeutics
Using Lactose and Ultrasound to deliver chemotherapeuitcs
dc.type.none.fl_str_mv info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/doctoralThesis
description A Master of Science thesis in Biomedical Engineering by Rand Hasan Abusamra entitled, “Using Lactose and Ultrasound to deliver chemotherapeutics”, submitted in May 2019. Thesis advisor is Dr. Ghaleb Husseini. Soft and hard copy available.
format doctoralThesis
id aus_8a6aa23c46233d9413c0fe054d8b8aa3
identifier_str_mv 35.232-2019.07
language_invalid_str_mv en_US
network_acronym_str aus
network_name_str aus
oai_identifier_str oai:repository.aus.edu:11073/16440
publishDate 2019
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Using Lactose and Ultrasound to deliver chemotherapeuticsUsing Lactose and Ultrasound to deliver chemotherapeuitcsAbusamra, Rand HasanDrug DeliveryChemotherapyLiposomesLactobionic Acid UltrasoundKinetic modelingChemotherapyDrug delivery systemsUltrasonics in medicineLactoseNanobiotechnologyA Master of Science thesis in Biomedical Engineering by Rand Hasan Abusamra entitled, “Using Lactose and Ultrasound to deliver chemotherapeutics”, submitted in May 2019. Thesis advisor is Dr. Ghaleb Husseini. Soft and hard copy available.As the number of cancer patients increase, so does the number of patients that undergo chemotherapy, as well as the suffering, caused by its side effects. To solve this adversity, an innovative form of delivering chemotherapeutics and reducing their adverse effects is envisioned through the use of nanocarriers and ultrasound. Nanocarriers; dendrimers, solid lipid nanoparticles, micelles, and liposomes can be used to exploit passive targeting and the enhanced permeability and retention (EPR) effect found in cancerous tumors. For maximum accumulation at the tumor site, active targeting, and receptor-mediated endocytosis, via the conjugation of specific ligands, including carbohydrates, small molecules, proteins, and antibodies, are utilized. The controlled release of chemotherapeutics at the tumor site is then achieved by an external or internal trigger. Hepatocellular carcinoma has been found to overexpress the Asiaglycoprotein Receptor (ASGPR). Therefore, liposomes are synthesized through the lipid film hydration method and conjugated with Lactobionic acid (LA) as a targeting moiety. Infrared spectroscopy and phenol-sulfuric acid assay confirmed the attachment and molecular structure. Dynamic Light Scattering (DLS) determined the size and dispersity of the lactosylated liposome and NH2 liposomes encapsulating calcein to be 85.7±1.2 nm and 89.2±2.7 nm, respectively. Controlled release of calcein (a model drug), is achieved through low-frequency Ultrasound (US) as an external trigger at 3 power intensities of 7.46, 9.85 and 17.31 mW/cm2. The release mechanism was studied using nine different mathematical kinetic models: zero-order, first-order, Higuchi, Hixon-Crowell, Korsmeyer-Peppas, Baker-Lonsdale, Weibull, Hopfenberg and Gompertz. The release data were found to follow the Weibull model, having the highest coefficient of determination (R2). Control liposomes followed first-order release Fickian diffusion and LA liposomes had a combined release of Fickian and case II diffusion with a b-value of 1.0 and 0.91, respectively. The results of this thesis show the utility of using targeted liposomes and ultrasound in cancer treatment.College of EngineeringMultidisciplinary ProgramsMaster of Science in Biomedical Engineering (MSBME)Husseini, Ghaleb2019-05-21T09:54:28Z2019-05-21T09:54:28Z2019-05info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisapplication/pdfapplication/pdf35.232-2019.07http://hdl.handle.net/11073/16440en_USoai:repository.aus.edu:11073/164402025-06-26T12:08:33Z
spellingShingle Using Lactose and Ultrasound to deliver chemotherapeutics
Abusamra, Rand Hasan
Drug Delivery
Chemotherapy
Liposomes
Lactobionic Acid Ultrasound
Kinetic modeling
Chemotherapy
Drug delivery systems
Ultrasonics in medicine
Lactose
Nanobiotechnology
status_str publishedVersion
title Using Lactose and Ultrasound to deliver chemotherapeutics
title_full Using Lactose and Ultrasound to deliver chemotherapeutics
title_fullStr Using Lactose and Ultrasound to deliver chemotherapeutics
title_full_unstemmed Using Lactose and Ultrasound to deliver chemotherapeutics
title_short Using Lactose and Ultrasound to deliver chemotherapeutics
title_sort Using Lactose and Ultrasound to deliver chemotherapeutics
topic Drug Delivery
Chemotherapy
Liposomes
Lactobionic Acid Ultrasound
Kinetic modeling
Chemotherapy
Drug delivery systems
Ultrasonics in medicine
Lactose
Nanobiotechnology
url http://hdl.handle.net/11073/16440